Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

Similar articles for PubMed (Select 22586591)

1.

Methazolamide is a new hepatic insulin sensitizer that lowers blood glucose in vivo.

Konstantopoulos N, Molero JC, McGee SL, Spolding B, Connor T, de Vries M, Wanyonyi S, Fahey R, Morrison S, Swinton C, Jones S, Cooper A, Garcia-Guerra L, Foletta VC, Krippner G, Andrikopoulos S, Walder KR.

Diabetes. 2012 Aug;61(8):2146-54. doi: 10.2337/db11-0578. Epub 2012 May 14.

2.

Treatment of Obese Insulin-Resistant Mice with an Allosteric MAPKAPK2/3 Inhibitor Lowers Blood Glucose and Improves Insulin Sensitivity.

Ozcan L, Xu X, Deng SX, Ghorphade DS, Thomas T, Cremers S, Hubbard B, Serrano-Wu MH, Gaestel M, Landry DW, Tabas I.

Diabetes. 2015 Jun 11. pii: db141945. [Epub ahead of print]

PMID:
26068544
3.

Metformin suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-+Leprdb/+Leprdb mice.

Ohno T, Shimizu M, Shirakami Y, Baba A, Kochi T, Kubota M, Tsurumi H, Tanaka T, Moriwaki H.

PLoS One. 2015 Apr 16;10(4):e0124081. doi: 10.1371/journal.pone.0124081. eCollection 2015.

4.

Effects and molecular mechanisms of the antidiabetic fraction of Acorus calamus L. on GLP-1 expression and secretion in vivo and in vitro.

Liu YX, Si MM, Lu W, Zhang LX, Zhou CX, Deng SL, Wu HS.

J Ethnopharmacol. 2015 May 26;166:168-75. doi: 10.1016/j.jep.2015.03.014. Epub 2015 Mar 17.

PMID:
25792018
5.

Combination therapy with oleanolic acid and metformin as a synergistic treatment for diabetes.

Wang X, Chen Y, Abdelkader D, Hassan W, Sun H, Liu J.

J Diabetes Res. 2015;2015:973287. doi: 10.1155/2015/973287. Epub 2015 Feb 18.

6.

Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechanisms.

Cifarelli V, Lashinger LM, Devlin KL, Dunlap SM, Huang J, Kaaks R, Pollak MN, Hursting SD.

Diabetes. 2015 May;64(5):1632-42. doi: 10.2337/db14-1132. Epub 2015 Jan 9.

PMID:
25576058
7.

Hypoglycemic effect of deoxynojirimycin-polysaccharide on high fat diet and streptozotocin-induced diabetic mice via regulation of hepatic glucose metabolism.

Li YG, Ji DF, Zhong S, Lin TB, Lv ZQ.

Chem Biol Interact. 2015 Jan 5;225:70-9. doi: 10.1016/j.cbi.2014.11.003. Epub 2014 Nov 20.

PMID:
25446853
8.

Evaluation of hypoglycemic efficacy of tangningtongluo formula, a traditional Chinese Miao medicine, in two rodent animal models.

Cheng L, Meng XB, Lu S, Wang TT, Liu Y, Sun GB, Sun XB.

J Diabetes Res. 2014;2014:745419. doi: 10.1155/2014/745419. Epub 2014 Nov 5.

9.

In vivo hypoglycaemic effect and inhibitory mechanism of the branch bark extract of the mulberry on STZ-induced diabetic mice.

Liu HY, Fang M, Zhang YQ.

ScientificWorldJournal. 2014;2014:614265. doi: 10.1155/2014/614265. Epub 2014 Aug 6.

10.

Preclinical characterization of recombinant human tissue kallikrein-1 as a novel treatment for type 2 diabetes mellitus.

Kolodka T, Charles ML, Raghavan A, Radichev IA, Amatya C, Ellefson J, Savinov AY, Nag A, Williams MS, Robbins MS.

PLoS One. 2014 Aug 6;9(8):e103981. doi: 10.1371/journal.pone.0103981. eCollection 2014.

11.

Metformin supports the antidiabetic effect of a sodium glucose cotransporter 2 inhibitor by suppressing endogenous glucose production in diabetic mice.

Neschen S, Scheerer M, Seelig A, Huypens P, Schultheiss J, Wu M, Wurst W, Rathkolb B, Suhre K, Wolf E, Beckers J, Hrabé de Angelis M.

Diabetes. 2015 Jan;64(1):284-90. doi: 10.2337/db14-0393. Epub 2014 Jul 28.

12.

Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer.

Suh JM, Jonker JW, Ahmadian M, Goetz R, Lackey D, Osborn O, Huang Z, Liu W, Yoshihara E, van Dijk TH, Havinga R, Fan W, Yin YQ, Yu RT, Liddle C, Atkins AR, Olefsky JM, Mohammadi M, Downes M, Evans RM.

Nature. 2014 Sep 18;513(7518):436-9. doi: 10.1038/nature13540. Epub 2014 Jul 16. Erratum in: Nature. 2015 Apr 16;520(7547):388.

13.

Cathepsin S inhibition lowers blood glucose levels in mice.

Lafarge JC, Pini M, Pelloux V, Orasanu G, Hartmann G, Venteclef N, Sulpice T, Shi GP, Clément K, Guerre-Millo M.

Diabetologia. 2014 Aug;57(8):1674-83. doi: 10.1007/s00125-014-3280-2. Epub 2014 Jun 3.

PMID:
24891017
14.

Identification of a small molecular insulin receptor agonist with potent antidiabetes activity.

Qiang G, Xue S, Yang JJ, Du G, Pang X, Li X, Goswami D, Griffin PR, Ortlund EA, Chan CB, Ye K.

Diabetes. 2014 Apr;63(4):1394-409. doi: 10.2337/db13-0334.

15.

B-cell translocation gene 2 regulates hepatic glucose homeostasis via induction of orphan nuclear receptor Nur77 in diabetic mouse model.

Kim YD, Kim SG, Hwang SL, Choi HS, Bae JH, Song DK, Im SS.

Diabetes. 2014 Jun;63(6):1870-80. doi: 10.2337/db13-1368. Epub 2014 Mar 19.

16.

Colestimide improves glycemic control via hepatic glucose production in db/db mice.

Yamakawa T, Ogihara K, Utsunomiya H, Muraoka T, Kadonosono K, Terauchi Y.

Endocr J. 2014;61(5):425-36. Epub 2014 Feb 19.

17.

Mibefradil reduces blood glucose concentration in db/db mice.

Lu Y, Long M, Zhou S, Xu Z, Hu F, Li M.

Clinics (Sao Paulo). 2014 Jan;69(1):61-7. doi: 10.6061/clinics/2014(01)09.

18.

Improvement of insulin sensitivity by a novel drug candidate, BGP-15, in different animal studies.

Literáti-Nagy B, Tory K, Peitl B, Bajza Á, Korányi L, Literáti-Nagy Z, Hooper PL, Vígh L, Szilvássy Z.

Metab Syndr Relat Disord. 2014 Mar;12(2):125-31. doi: 10.1089/met.2013.0098. Epub 2014 Jan 4.

PMID:
24386957
19.

Effects of two weeks of metformin treatment on whole-body glycocalyx barrier properties in db/db mice.

Eskens BJ, Zuurbier CJ, van Haare J, Vink H, van Teeffelen JW.

Cardiovasc Diabetol. 2013 Dec 5;12:175. doi: 10.1186/1475-2840-12-175.

20.

Potential utility of sodium selenate as an adjunct to metformin in treating type II diabetes mellitus in rats: a perspective on protein tyrosine phosphatase.

Salama RM, Schaalan MF, Elkoussi AA, Khalifa AE.

Biomed Res Int. 2013;2013:231378. doi: 10.1155/2013/231378. Epub 2013 Sep 11.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk